140118-17-8

Basic information

• Product Name: 4-Chloro-6-(3-methoxy-phenyl)-pyrimidine
• Synonyms: 4-Chloro-6-(3-methoxy-phenyl)-pyrimidine
• CAS NO: 140118-17-8
• Molecular Formula: C₁₁H₉ClN₂O
• Molecular Weight: 220.65496
• Mol File: 140118-17-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Chloro-6-(3-methoxy-phenyl)-pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-6-(3-methoxy-phenyl)-pyrimidine(140118-17-8)
• EPA Substance Registry System: 4-Chloro-6-(3-methoxy-phenyl)-pyrimidine(140118-17-8)

Safety Data

• Hazardous Substances Data: 140118-17-8(Hazardous Substances Data)

Upstream product

• 1193-21-1 4,6-dichloropyrimidine 
• 10365-98-7 3-methoxyphenylboronic acid 

Downstream Products

• 69491-45-8 4-(3-methoxyphenyl)pyrimidine 
• 1606169-35-0 ethyl (3-{[6-(3-methoxyphenyl)pyrimidin-4-yl]amino}benzyl)propylphosphinate 

Relevant articles and documents

Synthesis of 4-aryl and unsymmetrical 4,6-diarylpyrimidines by the Suzuki-Miyaura cross-coupling reaction

A two-step procedure for the synthesis of 4-arylpyrimidines from inexpensive 4,6-dichloropyrimidine via a Suzuki-Miyaura/hydrodechlorination reaction sequence is described. The reaction resulted in the predominant formation of mono-arylated product. The c

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors

Although there is a significant effort in the design of a selective CDK9/CycT1 inhibitor, no compound has been proven to be a specific inhibitor of this kinase so far. The aim of this research was to develop novel and selective phosphorus containing CDK9/CycT1 inhibitors. Molecules bearing phosphonamidate, phosphonate, and phosphinate moieties were synthesized. Prepared compounds were evaluated in an enzymatic CDK9/CycT1 assay. The most potent molecules were tested in cell-based toxicity and HIV proliferation assays. Selectivity of shortlisted compounds against CDKs and other kinases was tested. The best compound was shown to be a highly specific, ATP-competitive inhibitor of CDK9/CycT1 with antiviral activity.

(3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: Synthesis, in vitro, in vivo, and X-ray crystallographic characterization

A series of pyrrolidine based inhibitors of dipeptidyl peptidase IV were developed from a high throughput screening hit for the treatment of type 2 diabetes. Potency, selectivity, and pharmacokinetic properties were optimized resulting in the identification of a pre-clinical candidate for further profiling.

SUBSTITUTED PYRIMIDIN-4-YLAMINA ANALOGUES AS VANILLOID RECEPTOR LIGANDS

Substituted pyrimidyl-4-ylamine analogues are provided, of the Formula: (I) wherein variables are as described herein. Such compounds are ligands that may be used to modulate Vanilloid receptor activity in vivo or in vitro, and are particularly useful in

Pyrimidyl-substituted acrylic esters

There are described new pyrimidyl-substituted acrylic esters of the general formula (I) STR1 in which Py, X, R1 and R2 have the meaning given in the description, a process for their preparation, and new intermediates. The compounds of the formula (I) are used as pesticides.